Giannouli S, Voulgarelis M, Ziakas PD, et al. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment[J]. Ann Rheum Dis, 2006, 65(2): 144-148.
[2]
Meyer RJ, Hoffman R, Zanjani ED. Autoimmune hemolytic anemia and periodic pure red cell aplasia in systemic lupus erythematosus[J]. Am J Med, 1978, 65(2): 342-345.
[3]
Habib GS, Saliba WR, Froom P. Pure red cell aplasia and lupus[J]. Semin Arthritis Rheum, 2002, 31(4): 279-283.
[4]
Hara A, Wada T, Kitajima S, et al. Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies[J]. Am J Hematol, 2008, 83(9): 750-752.
Lichtman MA, Kipps TJ, Seligsohn U, et al. Williams Hematology[M]. 8th ed. New York: Mcgraw-Hill, 2010: 753-756.
[8]
Kiely PD, McGuckin CP, Collins DA, et al. Erythrocyte aplasia and systemic lupus erythematosus[J]. Lupus, 1995, 4(5): 407-411.
[9]
Dessypris EN, Krantz SB, Roloff JS, et al. Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children[J]. Blood, 1982, 59(1): 114-123.
[10]
Casadevall N, Dupuy E, Molho-Sabatier P, et al. Autoantibodies against erythropoietin in a patient with pure red-cell aplasia[J]. N Engl J Med, 1996, 334(10): 630-633.
[11]
Voulgarelis M, Kokori SI, Ioannidis JP, et al. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin[J]. Ann Rheum Dis, 2000, 59(3): 217-222.
[12]
Schett G, Firbas U, Fureder W, et al. Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus[J]. Rheumatology(Oxford), 2001, 40(4): 424-431.
[13]
Orbach H, Ben-Yehuda A, Ben-Yehuda D, et al. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin[J]. J Rheumatol, 1995, 22(11): 2166-2169.
